CHARLENE WALTON WINDHAM: Open Payments
NPI 1518336080 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 14 payments from 12 companies in 2025. Trend: 2023 $768 · 2024 $352 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $239 |
| Medtronic, Inc. | 1 | $132 |
| GENZYME CORPORATION | 1 | $126 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
Products named: COBENFY, SYMPLICITY G3, CERDELGA, UBRELVY, CAPLYTA, Wegovy, BENLYSTA, UZEDY.
Industry payments across MI — which companies pay providers there.
